Latigo Biotherapeutics LTGO

US equityMarket cap rank #3223Biotechnology

$15.52 −$0.74 (-4.55%)

Market closed · Oct 8, 7:00 am ET · Last extended-hours $15.89 +2.38%

Open$16.22

Prev close$16.26

Day range$15.27 – $16.35

Volume241.5K

Market cap$1.03B

P/E (TTM)–

Dividend yield–

Analyst view

ConsensusBuy

Analysts3

Average target$57.67+271.6% vs. price

Low $50.00Now $15.52Avg $57.67High $73.00

The last 3 actions on file set price targets from $50.00 to $73.00, averaging $57.67.

Date	Firm	Rating	Target
1 Sep 2026	Jefferies	BUY	$50.00
1 Sep 2026	Goldman Sachs	BUY	$73.00
1 Sep 2026	Guggenheim	BUY	$50.00

No comments yet — be the first to weigh in on LTGO.